Price Alert

Harrow Health Inc. 8.625%... (HROWL)

NASDAQ: HROWL · Real-Time Price · USD

25.47

0.12 (0.47%)

At close: Aug 18, 2025, 3:50 PM

25.47

0.00%

After-hours: Aug 18, 2025, 04:04 PM EDT

Harrow Health 8.625% Senior Notes due 2026 Statistics

Share Statistics

Harrow Health 8.625% Senior Notes due 2026 has 43.5M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	43.5M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	43
FTD / Avg. Volume	0.56%

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.81
Forward PS	n/a
PB Ratio	5.16
P/FCF Ratio	n/a
PEG Ratio	undefined

Financial Ratio History

Enterprise Valuation

Harrow Health 8.625% Senior Notes due 2026 has an Enterprise Value (EV) of 481.72M.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of undefined.

Current Ratio	2.83
Quick Ratio	2.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	undefined

Financial Efficiency

Return on Equity is -0.34% and Return on Invested Capital is 0.17%.

Return on Equity	-0.34%
Return on Assets	-0.08%
Return on Invested Capital	0.17%
Revenue Per Employee	$599.97K
Profits Per Employee	$-112.49K
Employee Count	217
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	701K
Effective Tax Rate	-0.03%

Stock Price Statistics

The stock price has increased by 3.82% in the last 52 weeks. The beta is 0.14, so Harrow Health 8.625% Senior Notes due 2026's price volatility has been higher than the market average.

Beta	0.14
52-Week Price Change	3.82%
50-Day Moving Average	25.3
200-Day Moving Average	25.25
Relative Strength Index (RSI)	51.64
Average Volume (20 Days)	7,612

Income Statement

In the last 12 months, Harrow Health 8.625% Senior Notes due 2026 had revenue of 130.19M and earned -24.41M in profits. Earnings per share was -0.75.

Revenue	130.19M
Gross Profit	90.55M
Operating Income	431K
Net Income	-24.41M
EBITDA	9.72M
EBIT	431K
Earnings Per Share (EPS)	-0.75

Full Income Statement

Balance Sheet

The company has 74.08M in cash and 190.5M in debt, giving a net cash position of -116.42M.

Cash & Cash Equivalents	74.08M
Total Debt	190.5M
Net Cash	-116.42M
Retained Earnings	-133.9M
Total Assets	351.54M
Working Capital	52.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.84M and capital expenditures -152.55M, giving a free cash flow of -148.71M.

Operating Cash Flow	3.84M
Capital Expenditures	-152.55M
Free Cash Flow	-148.71M
FCF Per Share	-4.56

Full Cash Flow Statement

Margins

Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.

Gross Margin	69.55%
Operating Margin	0.33%
Pretax Margin	-18.21%
Profit Margin	-18.75%
EBITDA Margin	7.47%
EBIT Margin	0.33%
FCF Margin	-114.23%

Dividends & Yields

HROWL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	-2.96%
FCF Yield	-13.51%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for HROWL.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	2.14
Piotroski F-Score	4